Liquid Biopsy Cancer Screening
A liquid biopsy is a blood-based test designed to detect and monitor signs of cancerous tumors, while traditional testing methods typically require a surgical biopsy. Moreover, a liquid biopsy test is optimal for early cancer detection, treatment response monitoring, when tumor tissue is insufficient or unavailable, or the patient needs a non-invasive option. Cancerous tumors release circulating tumor DNA (ctDNA) and cells (CTCs) into the bloodstream throughout their lifecycle. A liquid biopsy identifies and analyzes genetic biomarkers from this circulating tumor material to allow for precise characterization of cancer through the use of comprehensive or targeted panels of distinctive tumor variants. Knowledge of the genetic basis of cancer is
crucial for informing effective and prompt treatment.
We offer comprehensive cancer screening support – including bioinformatics for clinical trials, retrospective studies, or method comparisons. Our team of experts can run all of the panels on the list below or any custom panel.
Need to create a custom panel or solution?
We have experience in whole genome/exome/transcriptome sequencing, RNA-Seq, minimal residual disease (MRD) monitoring, and bespoke solutions. We also offer the following validated panels.
Frequently Requested Panels
|
|
|
Schedule a consultation with our research team to discuss your specific needs.